Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our ASX 100 model.
We see Ramsay Healthcare as a defensive position within the current volatile market conditions.
Buying support should develop within the $52 to $56 price band.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Our recent buy recommendations, Sonic Healthcare and Coles have rallied 10% over the past week.
Investors can now lock in the profit or sell at the money call options to enhance the yield.
SHL up 10%
COL up 11%
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
ASX is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
We recommend investors buy ASX and we reaffirm our “high conviction” rating.
Lendlease is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
The stock is also part of our ASX “high conviction” portfolio.
Orica is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Goldman Sachs raised $500 million in acquisition funding for ORI via an institutional placement.
The funds will be used for the acquisition of Exsa, Peru’s No. 1 manufacturer and distributor of industrial explosives and provide greater balance sheet flexibility.
We see strong buying support at $20.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.